IMPL

Impel Pharmaceuticals Inc. Common Stock
IMPL

Overview Fund Activity
Delisted

IMPL was delisted on the 15th of December, 2023.

Back to rankings

45 hedge funds and large institutions have $132M invested in Impel Pharmaceuticals Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 11 closing their positions.

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
0.69%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
14
Increased
17
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$1.8M
2
Two Sigma Investments
2
Two Sigma Investments
New York
$1.23M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.24M
4
DA
4
DCF Advisers
Connecticut
$2.21M
5
BlackRock
5
BlackRock
New York
$3.06M

Top Sellers

1
AAP
1
Ardsley Advisory Partners
Connecticut
$0
2
Russell Investments Group
2
Russell Investments Group
United Kingdom
$0
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$0
4
WP
4
Woodline Partners
California
$0
5
Victory Capital Management
5
Victory Capital Management
Texas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MS
51
Maven Securities
Jersey
– – -25,000 Closed
KWMG
52
King Wealth Management Group
Florida
– – -20,000 Closed
VF
53
Virtu Financial
New York
– – -11,381 Closed
FIA
54
FNY Investment Advisers
New York
– – -5,377 Closed
CAPTRUST Financial Advisors
55
CAPTRUST Financial Advisors
North Carolina
– – -140 Closed
CFGS
56
Concourse Financial Group Securities
Alabama
– – – –
EI
57
Ellevest Inc
New York
$0 12 +12 New
1 2
3